These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 7960392)

  • 1. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
    Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
    Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire.
    Cutts FT; Nyandu B; Markowitz LE; Forsey T; Zell ER; Othepa O; Wilkins K
    Vaccine; 1994 Nov; 12(14):1311-6. PubMed ID: 7856296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
    Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child mortality after high-titre measles vaccines: prospective study in Senegal.
    Garenne M; Leroy O; Beau JP; Sene I
    Lancet; 1991 Oct; 338(8772):903-7. PubMed ID: 1681265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life.
    Taylor WR; Mambu RK; ma-Disu M; Weinman JM
    Am J Epidemiol; 1988 Apr; 127(4):788-94. PubMed ID: 3354544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal.
    Samb B; Aaby P; Whittle H; Seck AM; Simondon F
    Trans R Soc Trop Med Hyg; 1993; 87(6):697-701. PubMed ID: 8296384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The control of measles in tropical Africa: a review of past and present efforts.
    Ofosu-Amaah S
    Rev Infect Dis; 1983; 5(3):546-53. PubMed ID: 6879012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
    Aaby P; Ibrahim SA; Libman MD; Jensen H
    Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.